Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2025-11-06 00:00:00 ET · period of report 2025-11-05 · accession 0001104659-25-107422 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-06 | 2025-11-05 | NVCT | Sanchez Juan | Dir | P - Purchase | $5.79 | +13.0K | 78.2K | +20% | +$75.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-05 | P | A | 13,000 | $5.79 | 78,150 | D | — | — | (F1) Reflects the weighted average purchase price. The range of prices for the shares purchased was $5.77 to $5.81. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. |